首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >lnactive conformation of the serpin α1-antichymotrypsin indicates two-stage insertion of the reactive loop: Implications for inhibitory function and conformational disease
【24h】

lnactive conformation of the serpin α1-antichymotrypsin indicates two-stage insertion of the reactive loop: Implications for inhibitory function and conformational disease

机译:丝氨酸蛋白酶抑制剂α1-抗胰凝乳蛋白酶的无效构象表明反应环的两阶段插入:对抑制功能和构象疾病的影响

获取原文
获取原文并翻译 | 示例
       

摘要

The serpins are a family of proteinase inhibitors that play a central role in the control of proteolytic cascades. Their inhibitory mechanism depends on the intramolecular insertion of the reactive loop into β-sheet A after cleavage by the target proteinase. Point mutations within the protein can allow aberrant con formational transitions characterized by β-strand exchange between the reactive loop of one molecule and β-sheet A of another. These loop-sheet polymers result in diseases as varied as cirrhosis, emphysema, angio-oedema, and thrombosis, and we recently have shown that they underlie an early-onset dementia. We report here the biochemical characteristics and crystal strudure of a naturally occurring variant (Leu-55--Pro) of the plasma serpin α1-antichymotrypsin trapped as an inactive inter- mediate. The structure demonstrates a serpin configuration with partial insertion of the reactive loop into p-sheet A. The lower part of the sheet is filled by the last turn of F-helix and the loop that links it to s3A. This con formation matches that of proposed intermediates on the pathway to complex and polymer formation in the serpins. In particular, this intermediate. along with the latent and polymerized con formations, explains the loss of activity of plasma α1-antichymo- trypsin associated with chronic obstructive pulmonary disease in patients with the Leu-55--Pro mutation.
机译:丝氨酸蛋白酶抑制剂是蛋白酶抑制剂的家族,在蛋白水解级联反应的控制中起着核心作用。它们的抑制机制取决于被靶蛋白酶切割后反应环在β-折叠A中的分子内插入。蛋白质内的点突变可允许异常构象转变,其特征在于一个分子的反应性环与另一分子的β-折叠A之间的β链交换。这些环板聚合物会导致各种疾病,如肝硬化,肺气肿,血管性水肿和血栓形成,并且我们最近已经表明它们是早发性痴呆的基础。我们在这里报告了血浆丝氨酸蛋白酶抑制蛋白α1-抗胰凝乳蛋白酶的天然存在变体(Leu-55-Pro)的生物化学特征和晶体结构,该变体被捕获为无活性的中间体。该结构展示了Serpin构型,其中将反应性回路部分插入了p-sheet A中。薄片的下部由F螺旋的最后一圈和将其链接到s3A的回路填充。这种构型与在丝氨酸蛋白酶抑制剂中形成络合物和聚合物的途径上拟议的中间体相匹配。特别是这种中间体。连同潜在和聚合的构象一起,解释了Leu-55-Pro突变患者血浆α1-抗胰凝乳蛋白酶与慢性阻塞性肺疾病相关的活性丧失。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号